Fungal biofilm inhibition by a component naturally produced by Candida albicans yeasts growing as a biofilm

International Journal of Antimicrobial Agents

Volumn 31, Issue 2, 2008, Pages 166-170

  Cateau, Estelle ^a   Berjeaud, Jean Marc ^a   Rodier, Marie Hélène ^a   Imbert, Christine ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Anti biofilm activity; Biofilm; Candida albicans

Indexed keywords

SILICONE;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CATHETER INFECTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG PURIFICATION; FUNGUS GROWTH; GROWTH INHIBITION; HYDROPHILICITY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STRAIN IDENTIFICATION; ULTRAFILTRATION;

BIOFILMS; CANDIDA ALBICANS; CATHETERIZATION; MICROBIAL SENSITIVITY TESTS; SILICON;

EID: 37649017841     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.10.004     Document Type: Article

References (14)

1. Hawser S.P., and Douglas L.J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62 (1994) 915-921
2. Chandra J., Kuhn D.M., Mukherjee P.K., Hoyer L.L., McCormick T., and Ghannoum M.A. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183 (2001) 5385-5394
3. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271 (1994) 1598-1601
4. Almirante B., Rodriguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
5. Mermel L.A., Farr B.M., Sherertz R.J., Raad I.I., O'Grady N., Harris J.S., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
6. Mukherjee P.K., Zhou G., Munyon R., and Ghannoum M.A. Candida biofilm: a well-designed protected environment. Med Mycol 43 (2005) 191-208
7. Nett J., and Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 9 (2006) 340-345
8. Enjalbert B., and Whiteway M. Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth. Eukaryot Cell 4 (2005) 1203-1210
9. Chen H., Fujita M., Feng Q., Clardy J., and Fink G.R. Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci USA 101 (2004) 5048-5052
10. Hornby J.M., Jensen E.C., Lisec A.D., Tasto J.J., Jahnke B., Shoemaker R., et al. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 67 (2001) 2982-2992
11. Cocuaud C., Rodier M.H., Daniault G., and Imbert C. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms. J Antimicrob Chemother 56 (2005) 507-512
12. Cateau E., Levasseur P., Borgonovi M., and Imbert C. The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin. Clin Microbiol Infect 13 (2007) 311-315
13. Alem M.A., Oteef M.D., Flowers T.H., and Douglas L.J. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 5 (2006) 1770-1779
14. Alem M.A., and Douglas L.J. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol 54 (2005) 1001-1005